TEMITOPE FOWORA: Open Payments
NPI 1972998086 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,270 in 141 payments from 25 companies in 2025. Trend: 2023 $3,482 · 2024 $7,093 · 2025 $3,270
Food & beverage: $3,050Consulting: $150Education: $70
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 14 | $650 |
| GlaxoSmithKline, LLC. | 27 | $483 |
| AstraZeneca Pharmaceuticals LP | 16 | $308 |
| Axsome Therapeutics, Inc. | 13 | $268 |
| Insmed, Inc. | 13 | $196 |
| Regeneron Healthcare Solutions, Inc. | 7 | $170 |
| Avadel CNS Pharmaceuticals, LLC | 6 | $140 |
| Grifols USA, LLC | 5 | $130 |
| Actelion Pharmaceuticals US, Inc. | 4 | $110 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $105 |
Products named: XYWAV, NUCALA, Sunosi, DUPIXENT, Arikayce, TRELEGY ELLIPTA, AIRSUPRA, LUMRYZ.
Industry payments across MD — which companies pay providers there.
